Search Results - "Litvak, Anya"

Refine Results
  1. 1
  2. 2

    Clinical characteristics and course of 63 patients with BRAF mutant lung cancers by Litvak, Anya M, Paik, Paul K, Woo, Kaitlin M, Sima, Camelia S, Hellmann, Matthew D, Arcila, Maria E, Ladanyi, Marc, Rudin, Charles M, Kris, Mark G, Riely, Gregory J

    Published in Journal of thoracic oncology (01-11-2014)
    “…Mutant BRAF is a driver oncogene found in 2% of lung adenocarcinomas and represents a target for therapy. We examined the clinical characteristics and course…”
    Get more information
    Journal Article
  3. 3

    Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging by Litvak, Anya M, Woo, Kaitlin, Hayes, Sara, Huang, James, Rimner, Andreas, Sima, Camelia S, Moreira, Andre L, Tsukazan, Maria, Riely, Gregory J

    Published in Journal of thoracic oncology (01-12-2014)
    “…Thymic carcinomas are rare cancers with limited data regarding outcomes, particularly for those patients with advanced disease. We identified patients with…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Bronchial and Thymic Carcinoid Tumors by Litvak, Anya, MD, Pietanza, M. Catherine, MD

    “…Bronchial and thymic carcinoids are rare. We present epidemiologic data and potential risk factors. The approach to bronchial and thymic carcinoid patients is…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Macroscopic lymphovascular invasion visualized on mammogram and magnetic resonance imaging: Initially misidentified as ductal carcinoma in situ but properly diagnosed by immunohistochemistry by Sanders, Linda M, Dardik, Michael, Modi, Lopa, Sanders, Alison Esteva, Schaefer, Sarah S, Litvak, Anya

    Published in SAGE open medical case reports (01-01-2017)
    “…Objectives: Lymphovascular invasion (LVI) is a pathologic, microscopic finding associated with invasive cancer, and is a poor prognostic indicator, but has no…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Racial disparities in the rate of cardiotoxicity of HER2‐targeted therapies among women with early breast cancer by Litvak, Anya, Batukbhai, Bhavina, Russell, Stuart D., Tsai, Hua‐Ling, Rosner, Gary L., Jeter, Stacie C., Armstrong, Deborah, Emens, Leisha A., Fetting, John, Wolff, Antonio C., Silhy, Raquel, Stearns, Vered, Connolly, Roisin M.

    Published in Cancer (01-05-2018)
    “…BACKGROUND Human epidermal growth factor receptor 2 (HER2)‐targeted therapies are highly effective at preventing breast cancer recurrence but are associated…”
    Get full text
    Journal Article
  11. 11
  12. 12

    False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer by Litvak, Anya, Cercek, Andrea, Segal, Neil, Reidy-Lagunes, Diane, Stadler, Zsofia K, Yaeger, Rona D, Kemeny, Nancy E, Weiser, Martin R, Pessin, Melissa S, Saltz, Leonard

    “…Routine monitoring of carcinoembryonic antigen (CEA) levels is standard in patients with resected colorectal cancer (CRC). The incidence of false-positives and…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Use of Chemotherapy in the Resection of Liver Metastases of Colorectal Cancer by Litvak, Anya, Saltz, Leonard

    Published in Current colorectal cancer reports (01-06-2013)
    “…R0 resection has proved curative in a subset of patients with colorectal liver metastases. Unfortunately, the incidence of recurrence is high. For this reason,…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Retrospective analysis of clinical outcomes of early stage ALK-positive (ALK+) non-small cell lung cancer (NSCLC) by Dagogo-Jack, Ibiayi, Santini, Fernando, Eng, Juliana, Yeap, Beow Y., Izar, Benjamin, Chin, Emily, Litvak, Anya, Jones, David Randolph, Kris, Mark G., Shaw, Alice Tsang, Gainor, Justin F., Chaft, Jamie E.

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only 8536 Background: ALK rearrangements are important oncogenic drivers in NSCLC. However, the prognostic implications of these rearrangements are…”
    Get full text
    Journal Article
  17. 17

    Radiogenomic evaluation of lung cancer — Are there imaging characteristics associated with lung adenocarcinomas harboring BRAF mutations? by Halpenny, Darragh F, Plodkowski, Andrew, Riely, Gregory, Zheng, Junting, Litvak, Anya, Moscowitz, Chaya, Ginsberg, Michelle S

    Published in Clinical imaging (01-03-2017)
    “…Abstract Introduction We studied computed tomography (CT) features associated with BRAF mutated lung cancer. Materials and m ethods CT features of BRAF mutated…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells by GOPALAN, Began, LITVAK, Anya, SHARMA, Sikha, MHASHILKAR, Abner M, CHADA, Sunil, RAMESH, Rajagopal

    Published in Cancer research (Chicago, Ill.) (15-04-2005)
    “…The tumor-suppressive activity of melanoma differentiation-associated gene-7 (mda-7), also known as interleukin 24 (IL-24), has been shown in a spectrum of…”
    Get full text
    Journal Article
  20. 20